McDermott Will & Schulte wins significant patent trial against Liquidia over YUTREPIA PH-ILD treatment
October 06, 2026
October 06, 2026
CHICAGO, Illinois, Oct. 6 [Category: BizLaw/Legal] -- McDermott Will and Emery, a law firm, issued the following news release:
* * *
McDermott Will & Schulte wins significant patent trial against Liquidia over YUTREPIA(r) PH-ILD treatment
*
Global law firm McDermott Will & Schulte secured a significant trial victory on behalf of United Therapeutics Corporation (UTC) in its Hatch-Waxman litigation against Liquidia Technologies in the US . . .
* * *
McDermott Will & Schulte wins significant patent trial against Liquidia over YUTREPIA(r) PH-ILD treatment
*
Global law firm McDermott Will & Schulte secured a significant trial victory on behalf of United Therapeutics Corporation (UTC) in its Hatch-Waxman litigation against Liquidia Technologies in the US . . .